Abstract
Objectives: This review systematically identifies posterior visual pathway lesions and MRI burden in people with multiple sclerosis (MS).
Methods: The articles were searched through Web of Science, Medline, and Embase databases on January 2020, for English language articles from 2000 to 2019.
Results: This review presents summary measures if related to MRI assessment to an overall measure of MS and visual pathway lesions. A total of 44 articles fulfilled all inclusion criteria, covering the period 2000-2019. Different atypical outcomes reveal a low risk for subsequent clinically predefined MS development, specifically in the presence of normal brain MRI. Several impairments related to quality of life have been identified as a result of the effect of retinal nerve fiber layer, ganglion cell layer, and inner plexiform layer.
Conclusion: The afferent visual system in MS offers unique accessibility and structure-related functions with further understanding offered by electrophysiology, considering vision as a useful framework for examining new multiple sclerosis therapies.
Footnotes
Disclosure. The Authors have no conflict of interests and the work was not supported or funded by any drug company.
- Received October 2, 2020.
- Accepted January 1, 2021.
- Copyright: © Neurosciences
Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.